Medidata offers trial decentralization platform

By The Science Advisory Board staff writers

June 16, 2021 -- Medidata has launched an end-to-end unified platform for the decentralization of clinical trials.

The company's Decentralized Clinical Trials Program unifies direct patient data capture technology with study oversight and monitoring, offering a high level of customization and enabling fully decentralized and hybrid studies.

The program captures data remotely, then aggregates and transforms that data, monitors it to identify quality issues, and runs analytics to gain insight into better outcomes for patients, researchers, sponsors, and contract research organizations.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.